Nitrosigine® Named as a 2015 NutrAward Finalist for Best New Functional Ingredient


PURCHASE, N.Y. February 18, 2015 – Nutrition 21, LLC, a fully owned subsidiary of JDS Therapeutics, LLC, and a leading developer and marketer of nutritional ingredients with health benefits substantiated by extensive research, is proud to announce that Nitrosigine® has been selected as a finalist for the Engredea 2015 NutrAward for best new Functional Ingredient.

Nitrosigine is a patented ingredient of bonded arginine silicate with FDA New Dietary Ingredient notification status; now affirmed as GRAS.^ It has been clinically shown to significantly boost nitric oxide (NO) levels.1 Nitric oxide is a key factor in increasing blood flow to working muscles. Nitrosigine is engineered to take effect in just 30 minutes, producing increased arginine levels that can last through an entire workout, for up to 3 hours1 – after just a single dose! With continued use, nitric oxide levels build over time.1 Increased NO levels can lead to even better blood flow and vessel flexibility.

Read the full press release here – Nitrosigine Nomination for Best New Functional Ingredient

To find out more about Nitrosigine, visit